News|Articles|January 2, 2024
Custom Traditional and Multi-Omics Media Development Enhances Antibody Production in CHO Cells (Jan 2024)
Author(s)Thermo Fisher Scientific
This case study summarizes the outcomes of several media optimization projects and how the results helped manufacturers to achieve their desired scale-up goals, including enhancing productivity, maintaining product quality, and potentially improving return on investment (ROI).
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
2
Clearing Hurdles in Sustainability, AI, and CDMO Partnerships
3
Excipient Innovation and the Regulatory Tug-of-War: Navigating Threats to Availability and Safety
4
US and European Pharma Manufacturing Face Diverging Paths to Resilience
5
